{
    "nct_id": "NCT02958774",
    "official_title": "Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation",
    "inclusion_criteria": "* Karnofsky Performance Status 50% - 100%\n* Diagnosis of stage II or III node-positive breast cancer (NOTE: Stages include: T4a-cNany, T3N1, TxN2.) OR T3N0 node-negative breast cancer.\n* For patients with TxN1 disease, one of the following criteria must be met: Grade 3; â‰¤ 45 years of age at time of screening for this study; extensive Lymphovascular Space Invasion (LVSI); 3 lymph nodes positive; hormone-negative disease; positive lymph nodes after chemotherapy; or extracapsular extension\n* Prior surgery and chemotherapy allowed, no prior radiation to the target area (breast or chest and nodes). NOTE: Radiation should occur 3-12 weeks after last chemotherapy or surgery, whichever comes last.\n* Women of child-bearing potential (WOCP) must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 90 days following completion of therapy.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Diagnosis of inflammatory breast cancer\n* Previously diagnosed malignancy excluding basal or squamous cell carcinoma of the skin (unless disease-free for 5 years or more)\n* Diagnosis of scleroderma\n* Diagnosis of lupus\n* Diagnosis of active dermatomyositis\n* Diagnosis of metastatic disease\n* Pregnant or nursing",
    "miscellaneous_criteria": ""
}